| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |